by Benzinga Insights | Jan 6, 2026 | General
Viking Therapeutics (NASDAQ:VKTX) has outperformed the market over the past 10 years by 15.18% on an annualized basis producing an average annual return of 28.75%. Currently, Viking Therapeutics has a market capitalization of $3.66 billion. Buying $100 In VKTX: If an...
by Erica Kollmann | Jan 6, 2026 | General
A new report from Hunterbrook Media investigates how the three biggest health care giants in the U.S.— CVS Health Corp. (NASDAQ:CVS), UnitedHealth Group, Inc. (NYSE:UNH) and Cigna Group (NYSE:CI) — are allegedly using shell companies to hide billions of dollars that...
by Chris Katje | Jan 6, 2026 | General
Palantir Technologies (NASDAQ:PLTR) ended 2025 as one of the most-searched tickers in Benzinga Pro thanks to a surge in interest from readers. The stock is seeing strong attention to start 2026 with a potential link to the recent military action carried out in...
by Benzinga Insights | Jan 6, 2026 | General
Cloudflare (NYSE:NET) has outperformed the market over the past 5 years by 8.14% on an annualized basis producing an average annual return of 20.95%. Currently, Cloudflare has a market capitalization of $69.26 billion. Buying $100 In NET: If an investor had bought...
by Benzinga Insights | Jan 6, 2026 | General
Nebius Group (NASDAQ:NBIS) has outperformed the market over the past 10 years by 9.0% on an annualized basis producing an average annual return of 22.58%. Currently, Nebius Group has a market capitalization of $24.90 billion. Buying $100 In NBIS: If an investor had...
Recent Comments